# Michael P. Dorsch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-p-dorsch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,548 |
| Field | Heart Failure Treatment and Management |
| h-index | 25 |
| i10-index | 54 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5054005073 |
| ORCID iD | 0000-0003-2910-1879 |
| Works | 184 |

## Researcher papers

- [2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation](https://scholariq.org/papers/2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial/)
- [New York, USA](https://scholariq.org/papers/new-york-usa/)
- [Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide](https://scholariq.org/papers/chlorthalidone-reduces-cardiovascular-events-compared-with-hydrochlorothiazide/)
- [Gerotechnology for Older Adults With Cardiovascular Diseases](https://scholariq.org/papers/gerotechnology-for-older-adults-with-cardiovascular-diseases/)
- [Vitamin D and Cardiovascular Disease](https://scholariq.org/papers/vitamin-d-and-cardiovascular-disease/)
- [The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding](https://scholariq.org/papers/the-real-world-use-of-combined-p-glycoprotein-and-moderate-cyp3a4-inhibitors/)
- [Mobile Applications to Improve Medication Adherence](https://scholariq.org/papers/mobile-applications-to-improve-medication-adherence/)
- [Effects of a Novel Contextual Just-In-Time Mobile App Intervention (LowSalt4Life) on Sodium Intake in Adults With Hypertension: Pilot Randomized Controlled Trial](https://scholariq.org/papers/effects-of-a-novel-contextual-just-in-time-mobile-app-intervention-lowsalt4life/)
- [A Randomized Crossover Comparison of Team-based Learning and Lecture Format on Learning Outcomes](https://scholariq.org/papers/a-randomized-crossover-comparison-of-team-based-learning-and-lecture-format-on/)
- [Indications for Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Evidence-Based Recommendations for Use](https://scholariq.org/papers/indications-for-dual-antiplatelet-therapy-with-aspirin-and-clopidogrel-evidence/)
- [Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl)](https://scholariq.org/papers/effects-of-total-dose-infusion-of-iron-intravenously-in-patients-with-acute/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Mobile Health and mHealth Applications](https://scholariq.org/topics/mobile-health-and-mhealth-applications/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.